DAWN
USDDay One Biopharmaceuticals Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$7.260
Kõrge
$7.490
Madal
$7.108
Maht
10.46M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
747.8M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.49M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
Commercial execution delivers best quarter launch-to-date with growth across all dimensions of core business Raising OJEMDA full-year 2025 net product revenue guidance to $145 to $150 million Three-year FIREFLY-1 data
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (NASDAQ:DAWN) ("Day One" or the "Company"), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for
Seotud aktsiad
ETB
Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund Common Shares of Beneficial Interest
RBOT
Vicarious Surgical Inc.
FDSB
Fifth District Bancorp Inc.
FWRD
Forward Air Corporation
SKGRW
SK Growth Opportunities Corporation Warrant
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.